Clinical trial
Bromocriptine and Insulin Sensitivity in Lean and Obese Subjects
NCT02428946 is registered in ClinicalTrials.gov with Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bromocriptine and Insulin Sensitivity in Lean and Obese Subjects
- Lead sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2014
- Completion date
- December 31, 2015
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
insulin sensitivity